Tranilast: A pharmaceutical candidate for reduction of adhesions using a novel approach

Seminars in Reproductive Medicine

Volumn 26, Issue 4, 2008, Pages 341-348

  Petrilli, Janel ^a   Wadsworth, Scott ^a   Cooper, Kevin ^b   Rodgers, Kathleen E ^c   Siekierka, John ^a   DiZerega, Gere S ^c  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b ETHICON INC   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adhesions; Gynecologic surgery; Mast cells; Surgery; Transilast

Indexed keywords

CARBOXYMETHYLCELLULOSE; CYTOKINE; PLACEBO; TRANILAST; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GEL; GYNECOLOGIC SURGERY; HUMAN; LAPAROSCOPIC SURGERY; NONHUMAN; PERITONEAL CAVITY; PERITONEUM ADHESION; PERITONEUM MAST CELL; POSTOPERATIVE COMPLICATION; REVIEW; WOUND HEALING;

ADHESIONS; ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EQUIPMENT AND SUPPLIES; FIBROSIS; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; PERITONEAL DISEASES; PERITONEUM;

EID: 50249103450     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082392     Document Type: Review

References (70)

1. Ray T, Larson JW Jr, Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271-276
2. Diamond MP, DeCherney AH. Pathogenesis of adhesion formation/reformation: application to reproductive pelvic surgery. Microsurgery 1987;8:103-107
3. Diamond MP, Daniell JF, Feste J, et al. Adhesion reformation and de novo adhesion formation following reproductive pelvic surgery. Fertil Steril 1987;47:864-866
4. Operative Laparoscopy Study Group. Postoperative adhesion development following operative laparoscopy: evaluation at early second-look procedures. Fertil Steril 1991;55:700
5. Diamond MP. Surgical aspects of infertility. In: Speroff L, Simpson JL, Sciarra JJ, eds. Obstetrics and Gynecology. Vol 5. Philadelphia, PA: JB Lippincott; 1991:1-23
6. Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9
7. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999;353:1476-1480
8. Kamffer WJ, Jooste EV, Nel JT, de Wet JI. Surgical glove powder and intraperitoneal adhesion formation. An appeal for the use of powder-free surgical gloves. S Afr Med J 1992;81:158-159
9. Weibel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973;126:345-353
10. Myllarniemi H, Frilander M, Turunen M, Saxen L. The effect of glove powders and their constituents on adhesion and granuloma formation in the abdominal cavity of rabbit. Acta Chir Scand 1966;131:312-318
11. Interceed (TC7) Adhesion Barrier Study Group. Prevention of postsurgical adhesions by Interceed (TC7), an absorbable adhesion barrier: a prospective, randomized multicenter clinical study. Fertil Steril 1989;51:933-938
12. Surrey MW, Friedman S. Second-look laparoscopy after reconstructive pelvic surgery for infertility. J Reprod Med 1982;27:658-660
13. diZerega GS. Contemporary adhesion prevention. Fertil Steril 1994;61:219-235
14. Galli SJ, Gordon JR, Wershil BK. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl 1993;43:209-220
15. Collins SM. The immunomodulation of gut motility: factors that determine the proliferation of mast cells in the sensitized gut. Gastroenterology 1988;94:74
16. Liebman SM, Langer JC, Marshall JS, Collins SM. Role of mast cells in peritoneal adhesion formation. Am J Surg 1993;165:127-130
17. Langer JC, Liebman SM, Monk PK, Pelletier GJ. Mast cell mediators and peritoneal adhesion formation in the rat. J Surg Res 1995;59:344-348
18. Xu X, Pappo O, Garbuzenko E, Bischoff SC, Rivkind A, Levi-Schaffer F. Mast cell dynamics and involvement in the development of peritoneal adhesion in the rat. Life Sci 2002;70:951-967
19. Levi-Schaffer F, Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy 1997;11:64-70
20. Levi-Schaffer F, Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp Cell Res 1990;188:42-49
21. Kupietzky A, Levi-Schaffer F. The role of mast cells-derived histamine in the closure of an in vitro wound. Inflamm Res 1996;45:176-180
22. Hatamochi A, Ueki H, Mauch C, Krieg T. Effect of histamine on collagen and non-collagen mRNA production in human skin fibroblasts. J Dermatol. Sci 1991;2:407-412
23. Claman H. Mast cells, T cells and abnormal fibrosis. Immunol Today 1985;6:192
24. Adachi S, Maruyama T, Kondo T, Todoroki T, Fukao K. Prevention of postoperative intraperitoneal adhesions by tranilast: N-(3′,4′- dimethoxycinnamoyl)anthranilic acid. Surg Today 1999;29:51-54
25. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 1997;557:24-31
26. Rubin J, Herrera GA, Collins D. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991;18:97-102
27. Remick DG, Strieter M, Lynch JP III, Nguyen D, Eskandari M, Kunkel SL. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Lab Invest 1989;60:766-771
28. Scott-Coombs DM. Peritoneal cytokine response in surgery. Br J Surg 1994;81:756
29. Suzawa H, Kikuchi S, Ichikawa K, Koda A. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 1992;60:85-90
30. Chikaraishi A, Hirahashi J, Takase O, et al. Tranilast inhibits interleukin-1beta-induced monocyte chemoattractant protein-1 expression in rat mesangial cells. Eur J Pharmacol 2001;427:151-158
31. Yanagi T, Watanabe M, Fukuda S, Tsuji Y. Suppressive effects of tranilast (TN) on human mononuclear cells. Jpn J Inflammation 1987;7:169-176
32. Mori H, Tanaka H, Kawada K, Nagai H, Koda A. Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis. Jpn J Pharmacol 1995;67:279-289
33. Ward MR, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A. Tranilast prevents activation of transforming growth factor-b system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol 2002;22:940-948
34. Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981;13:397-401
35. DiZerega GS, Campeau JD. Peritoneal repair and postsurgical adhesion formation. Hum Reprod Update 2001;7:547-555
36. Koyama S, Takagi H, Otani A, Suzuma K, Nishimura K, Honda Y. Tranilast inhibits protein kinase C-dependent signaling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells. Br J Pharmacol 1999;127:537-545
37. Isaji M, Miyata H, Ajisawa Y, Yoshimura N. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 1997;122:1061-1066
38. Squires CE, Escobar GP, Payne JF, et al. Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol 2005;39:699-707
39. Yasukawa T, Kimura H, Dong J, et al. Effect of Tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts. Ophthalmic Res 2002;34:206-212
40. Li Y, Foster W, Deasy BM, et al. Transforming growth factor-β1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;164:1007-1019
41. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002;161:895-907
42. Huard J, Yong L, Ferddie H. Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 2002;84:822-832
43. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994;10:1286-1292
44. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999;1:1349-1365
45. Bernasconi P, Torchiana E, Confalonieri P, et al. Expression of transforming growth factor-β1 in dystrophic patient muscles correlates with fibrosis. Pathogenic role of a fibrogenic cytokine. J Clin Invest 1995;96:1137-1144
46. Lundberg I, Ulfgren A, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-874
47. Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem (Tokyo) 1994;116:892-897
48. Suzawa H, Kikuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-96
49. Suzawa H, Kikuchi S, Ichikawa K, et al. Effect of tranilast, an antiallergic drug, on human keloid tissues. Nippon Yakurigaku Zasshi 1992;99:231-239
50. Ichikawa K, Suzawa H, Tsuchiya O, et al. Comparison of the effects of tranilast, triamcinolone, and a heparin-like substance on keloid and hypertrophic scar. Oyo Yakur 1992;43:401
51. Cohen IK, Keiser HR, Sjoerdsma A. Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 1971;22:488-489
52. Shigeki S, Murakami T, Yata N, Ikuta Y. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scand J Plast Reconstr Surg Hand Surg 1997;31:151-158
53. Taniguchi S, Yorifuji T, Hamada T. Treatment of linear localized scleroderma with the anti-allergic drug, Tranilast. Clin Exp Dermatol 1994;19:391-393
54. Pinto YM, Pinto-Sietsma SJ, Philipp T, et al. Reduction in left ventricular messenger RNA from transforming growth factor beta (1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat. Hypertension 2000;36:747-754
55. Mifsud S, Kelly DJ, Qi W, et al. Intervention with tranilast attenuates renal pathology and alburminuria in advanced experimental diabetic neuropathy. Nephron Physiol 2003;95:83-91
56. Martin J, Kelly DJ, Mifsud SA, et al. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-β. Cardiovasc Res 2005;65:691-694
57. Guidry C. The role of Muller cells in fibrocontractive retinal disorders. Prog Retin Eye Res 2005;24:75-86
58. Hocher B, Godes M, Olivier J, et al. Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension. J Hypertens 2002;20:745-751
59. Ward MR, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A. Tranilast prevents activation of transforming growth factor βsystem, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol 2002;22:940-948
60. Tamai H, Katoh O, Suzuki S, et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT). Am Heart J 1999;138:968-975
61. Holmes DR Jr, Savage M, LaBlanche JM, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002;106:1243-1250
62. Kosuga K, Tamai H, Ueda K, et al. Effectiveness of tranilast on restenosis after directional coronary atherectomy. Am Heart J 1997;134:712-718
63. Okada H, Kalluri R. Cellular and molecular pathyways that lead to progression and regression of renal fibrogenesis. Curr Mol Med 2005;5:467-474
64. Kelly DJ, Zhang Y, Gow R, Gilbert RE. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model. J Am Soc Nephrol 2004;15:2619-2629
65. Soma J, Sugawara T, Huang YD, Nakajima J, Kawamura M. Tranilast slows the progression of advanced diabetic nephropathy. Nephron 2002;92:693-698
66. Cooper K, Young J, Wadsworth S, Cui H, diZerega GS, Rodger KE. Reduction of post-surgical adhesion formation with Tranilast. J Surg Res 2007;141(2):153-161
67. Young J, Wadsworth S, Cooper K, Rosenblatt J, Cui H. Drug-enhanced adhesion prevention. United States Patent Application Publication. US 2005/0106229 A12005
68. Dullerud R, Graver V, Haakonsen M, Haaland AK, Loeb M, Magnaes B. Influence of fibrinolytic factors on scar formation after lumbar discectomy. A magnetic resonance imaging follow-up study with clinical correlation performed 7 years after surgery. Spine 1998;23:1464-1469
69. Rodgers KE, Robertson JT, Espinoza T, et al. Reduction of epidural fibrosis in lumbar surgery with Oxiplex adhesion barriers of carboxymethylcellulose and polyethylene oxide. Spine J 2003;3:277-283
70. Jaibaji M, Brody GS, Rodgers K, et al. A new model for experimental tendon adhesions in the chicken. Ann Plast Surg 2000;44:205-210